Esophageal Squamous Cell Carcinoma Clinical Trials in Wuhan, Hubei
3 recruitingWuhan, Hubei, China
Showing 1–3 of 3 trials
Recruiting
Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
Esophageal Squamous Cell CarcinomaPathological Complete ResponseDeep Learning+1 more
Tongji Hospital300 enrolled1 locationNCT07088354
Recruiting
Phase 2
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapies
Li Zhang43 enrolled1 locationNCT06165380
Recruiting
Phase 3
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Renmin Hospital of Wuhan University155 enrolled1 locationNCT05919030